Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Patients with diabetes mellitus and definite autonomic and peripheral neuropathy were randomized to receive quinapril or no treatment for 2 years.

• Phase: Phase 4

Details

• Lead Sponsor: Aristotle University Of Thessaloniki
• Treatments: Quinapril

Criteria

Inclusion Criteria:

• Diabetes mellitus with both autonomic and peripheral neuropathy

Exclusion Criteria:

• Hypertension, coronary heart disease